Cooper Companies Inc (COO) : First Mercantile Trust Co reduced its stake in Cooper Companies Inc by 7.41% during the most recent quarter end. The investment management company now holds a total of 3,721 shares of Cooper Companies Inc which is valued at $673,054 after selling 298 shares in Cooper Companies Inc , the firm said in a disclosure report filed with the SEC on Oct 7, 2016.Cooper Companies Inc makes up approximately 0.09% of First Mercantile Trust Co’s portfolio.
Other Hedge Funds, Including , Exxonmobil Investment Management Inc Tx added COO to its portfolio by purchasing 12,446 company shares during the most recent quarter which is valued at $2,251,232. Cooper Companies Inc makes up approx 0.05% of Exxonmobil Investment Management Inc Tx’s portfolio.Bnp Paribas Arbitrage Sa reduced its stake in COO by selling 19,626 shares or 90.57% in the most recent quarter. The Hedge Fund company now holds 2,043 shares of COO which is valued at $361,958.Independent Portfolio Consultants reduced its stake in COO by selling 70 shares or 5.19% in the most recent quarter. The Hedge Fund company now holds 1,280 shares of COO which is valued at $226,778. Cooper Companies Inc makes up approx 0.07% of Independent Portfolio Consultants’s portfolio. Chevy Chase Trust Holdings added COO to its portfolio by purchasing 40,815 company shares during the most recent quarter which is valued at $7,231,194. Cooper Companies Inc makes up approx 0.04% of Chevy Chase Trust Holdings’s portfolio.Eqis Capital Management reduced its stake in COO by selling 402 shares or 7.87% in the most recent quarter. The Hedge Fund company now holds 4,706 shares of COO which is valued at $833,762. Cooper Companies Inc makes up approx 0.05% of Eqis Capital Management’s portfolio.
Cooper Companies Inc opened for trading at $179.12 and hit $181.17 on the upside on Friday, eventually ending the session at $180.88, with a gain of 1.23% or 2.19 points. The heightened volatility saw the trading volume jump to 7,46,198 shares. Company has a market cap of $8,816 M.
On the company’s financial health, Cooper Companies Inc reported $2.30 EPS for the quarter, beating the analyst consensus estimate by $ 0.01 according to the earnings call on Sep 1, 2016. Analyst had a consensus of $2.29. The company had revenue of $514.70 million for the quarter, compared to analysts expectations of $512.63 million. The company’s revenue was up 11.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.97 EPS.
Many Wall Street Analysts have commented on Cooper Companies Inc. Company shares were Reiterated by BMO Capital Markets on Sep 2, 2016 to “Outperform”, Firm has raised the Price Target to $ 206 from a previous price target of $199 .Company shares were Reiterated by Stifel on Aug 31, 2016 to “Buy”, Firm has raised the Price Target to $ 215 from a previous price target of $195 .
The Cooper Companies Inc. (Cooper) is a global medical device company. The Company operates through two business units CooperVision Inc. (CVI) and CooperSurgical Inc. (CSI). CooperVision is a global manufacturer providing products for contact lens wearers. CooperSurgical focuses on supplying women’s health clinicians with products and treatment options to improve the delivery of healthcare to women. CooperSurgical products fall into three main segments based on the point of healthcare delivery: Hospital Office and Fertility Clinic. CooperVision develops manufactures and markets a range of monthly two-week and single-use contact lenses featuring advanced materials and optics. CooperVision is involved in correcting vision problems such as astigmatism presbyopia and ocular dryness and provides innovative contact lens solutions. The CooperVision Companys brands include Biofinity Avaira and MyDay and CooperSurgical Companys brands include Advincula Arch SeeClear and Mobius.